Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction
Excelerate Energy $384 million IPO
The stock is listed on the New York Stock Exchange
Brookfield $8.3 billion acquisition of CDK Global
We are advising Brookfield on the transaction
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction
Monarch Alternative Capital $150 million investment in The Honest Kitchen
We are advising Monarch Alternative Capital on the transaction
First Eagle Investments acquisition of Napier Park Global Capital
We are advising Napier Park on the transaction
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Williams $950 million acquisition of Haynesville assets from Trace Midstream
We are advising Williams on the transaction
SatixFy $813 million combination with Endurance Acquisition
We are advising SatixFy on the transaction
Provident Acquisition $1.02 billion combination with Perfect
We are advising Provident Acquisition, a SPAC, on the transaction